Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank77
3Y CAGR-23.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-23.0%/yr
Annual compound
Percentile
P77
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.25 | +144.4% |
| 2024 | 0.92 | -90.9% |
| 2023 | 10.07 | +104.4% |
| 2022 | 4.93 | -92.8% |
| 2021 | 68.75 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |